Table 2.
HPG | Biomarkers | groups | n | Mean (SD) | P-value |
---|---|---|---|---|---|
WDSCC | Ki67 | OSCC | 37 | 45.07 (4.66) | 0.018 |
OSCC-OSF | 63 | 42.93 (5.50) | |||
MVD | OSCC | 37 | 73.94 (10.90) | <0.001 | |
OSCC-OSF | 63 | 65.63 (8.20) | |||
α-SMA | OSCC | 37 | 1.21 (0.85) | 0.457 | |
OSCC-OSF | 63 | 1.33 (0.80) | |||
MDSCC | Ki67 | OSCC | 69 | 59.79 (10.55) | 0.48 |
OSCC-OSF | 37 | 58.71 (8.14) | |||
MVD | OSCC | 69 | 85.36 (13.51) | 0.905 | |
OSCC-OSF | 37 | 85.78 (11.47) | |||
α-SMA | OSCC | 69 | 2.42 (0.69) | 0.046 | |
OSCC-OSF | 37 | 2.16 (0.68) | |||
PDSCC | Ki67 | OSCC | 6 | 76.85 (6.48) | 0.361 |
OSCC-OSF | 5 | 71.87 (11.91) | |||
MVD | OSCC | 6 | 101.33 (12.24) | 0.714 | |
OSCC-OSF | 5 | 99.00 (13.07) | |||
α-SMA | OSCC | 6 | 3.00 (0.00) | 1.00 | |
OSCC-OSF | 5 | 3.00 (0.00) |
Histopathological grading, HPG; WDSCC, Well differentiated squamous cell carcinoma; MDSCC, Moderately differentiated squamous cell carcinoma; PDSCC, Poorly differentiated squamous cell carcinoma